Doctors Note Logo

Published on: 10/22/2026

Why MAOI Antidepressants Must Be Declared Before Anaesthesia

MAOI antidepressants (such as phenelzine, tranylcypromine, isocarboxazid, and selegiline) must be disclosed before any anaesthetic because they can interact dangerously with common anaesthetic and pain medications, most notably pethidine (meperidine) and other serotonergic opioids, triggering serotonin syndrome with fever, rigidity, agitation, and cardiovascular collapse. They can also cause severe blood pressure swings when combined with indirect-acting vasopressors like ephedrine, requiring your anaesthetist to choose alternative drugs and monitoring. Stopping an MAOI abruptly is not always the right answer, since withdrawal and relapse of depression carry their own risks, so the decision involves your prescriber, surgeon, and anaesthetist together. There are several important factors, timelines, and safe drug alternatives to consider, which are explained in full below.

If you are preparing for surgery, taking a psychiatric medication, or noticing new symptoms while on an antidepressant, it helps to get clarity before your pre-operative appointment so you can ask the right questions and flag the right details. A free, instant, online symptom check can help you organize what you are experiencing, understand possible causes, and identify the next steps worth discussing with your care team, all in just a few minutes and without any cost or waiting room.

Last reviewed for medical accuracy: 10/22/2026

answer background

Concerned about your symptoms?

Explanation

Why MAOI Antidepressants Must Be Declared Before Anaesthesia

Monoamine oxidase inhibitors (MAOIs) are older but still important antidepressants. They work by blocking the enzyme monoamine oxidase, which breaks down key brain chemicals like serotonin, norepinephrine and dopamine. Because of their unique effects—and potential interactions with many drugs—MAOIs require special attention when you’re preparing for surgery. If you’re taking an MAOI, telling your anesthesiologist and surgical team is essential for your safety.


How MAOIs Affect Neurotransmitters

  • Enzyme blockade: MAOIs inhibit monoamine oxidase (types A and B), raising levels of mood-related neurotransmitters.
  • Tyramine sensitivity: Foods high in tyramine (aged cheeses, cured meats, fermented products) can trigger sudden, severe blood pressure spikes when MAO is blocked.
  • Baseline risk: Even without anesthetic drugs, MAOIs carry a risk of hypertension, orthostatic hypotension and serotonin-related side effects.

Understanding these effects helps explain why certain anesthesia drugs can interact dangerously with MAOIs.


Major Risks During Anaesthesia

When you combine MAOIs with anesthetic agents or common surgical medications, two serious problems can occur:

1. Hypertensive Crisis

MAOIs block the breakdown of norepinephrine. If an indirect-acting pressor (like ephedrine) or certain anesthetics causes extra release of norepinephrine, blood pressure can skyrocket. Signs include severe headache, rapid heartbeat, chest pain and, in extreme cases, stroke.

2. Serotonin Syndrome

An excess of serotonin can lead to a life-threatening condition called serotonin syndrome. If an anesthetic contains serotonergic properties (for example, meperidine, tramadol or certain antiemetics like ondansetron), combining it with an MAOI may cause:

  • Agitation or confusion
  • High fever and muscle rigidity
  • Rapid heart rate and unstable blood pressure
  • Tremors, sweating, dilated pupils

Both conditions require immediate treatment to prevent lasting harm.


Specific Anaesthetic Agents to Avoid

When planning anesthesia, your provider will look carefully at your medication list. Some drugs are best avoided or used with extreme caution:

  • Meperidine (pethidine): High risk of serotonin syndrome.
  • Tramadol and methadone: Strong serotonergic effects.
  • Indirect-acting pressors: Ephedrine, pseudoephedrine and phenylpropanolamine can trigger a hypertensive crisis.
  • Certain inhalational agents: While modern volatile anesthetics (sevoflurane, isoflurane) are generally safer, interactions remain possible—especially if blood pressure swings occur.
  • MAOI interactions with sympathomimetics: Even decongestants or cold remedies with phenylephrine can be dangerous if taken close to surgery.

Safe Alternatives and Management Strategies

Experienced anesthesia teams can often work around MAOIs without stopping them. Options include:

  • Direct-acting vasopressors:

    • Phenylephrine or norepinephrine are preferred over ephedrine.
  • Non-serotonergic analgesics:

    • Fentanyl, hydromorphone or morphine instead of meperidine.
    • Regional blocks or local anesthetics to minimize systemic drugs.
  • Judicious fluid management:

    • Maintaining stable blood volume helps prevent extreme blood pressure changes.
  • Close monitoring:

    • Invasive arterial blood pressure lines in high-risk cases.
    • Continuous ECG and temperature monitoring to detect early signs of serotonin syndrome or hypertensive crisis.

Preoperative Steps

  1. Complete medication review:

    • List all prescriptions, over-the-counter drugs and supplements.
    • Highlight MAOIs (phenelzine, tranylcypromine, isocarboxazid, selegiline).
  2. Discuss timing of the last MAOI dose:

    • Some teams recommend pausing MAOIs 10–14 days before surgery.
    • Others continue therapy and adjust anesthesia accordingly to avoid risks of depression relapse.
  3. Plan ahead for emergencies:

    • Identify rescue medications for blood pressure control (nitroprusside, nitroglycerin).
    • Ensure dantrolene is available if severe serotonin syndrome or malignant hyperthermia is suspected.
  4. Coordinate with your psychiatrist or primary care doctor:

    • Any decision to stop or continue MAOIs should balance mental health stability and surgical safety.

Importance of Full Disclosure

  • Hidden medications can be dangerous. Even a single dose of an MAOI taken days before surgery can alter your reaction to anesthesia.
  • Anesthesiologists tailor care based on your full list. Undeclared MAOIs increase the risk of life-threatening complications.
  • You’re part of the safety team. Let every member of your healthcare team know which antidepressants you take.

Postoperative Care

After surgery, your care team will:

  • Monitor vital signs closely for any delayed blood pressure spikes or serotonin-related symptoms.
  • Restart MAOIs only when it’s safe, often 24–48 hours after anesthesia, once you can take oral medications and are hemodynamically stable.
  • Watch for drug interactions with postoperative pain medications, antiemetics and decongestants.

Clear communication continues to be key: if you develop unusual symptoms—headache, fever, tremor, extreme blood pressure changes—alert your nurse and doctor immediately.


Next Steps: Take Charge of Your Health

If you’re ever in doubt about any symptom—especially before surgery—you might consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help you understand what to share with your healthcare team.

Always speak to a doctor about any concerns that could be life threatening or serious. Your safety depends on clear, honest communication and expert planning when MAOIs and anesthesia meet.

(References)

  • * Davie IT. Specific drug interactions in anaesthesia. Anaesthesia. 1977 Nov-Dec;32(10):1000-8. doi: 10.1111/j.1365-2044.1977.tb09963.x. PMID: 23013.

  • * Drug fever. Med Lett Drugs Ther. 1975 Jul 18;17(15):63-4. PMID: 1152817.

  • * Weber E, Böhrer H, von Reumont D. [Extracardiac risk factors in heart surgery--drugs]. Z Kardiol. 1990;79 Suppl 4:71-8. PMID: 2082614.

  • * Friedlander AH. The dental management of the depressed patient. J Geriatr Psychiatry Neurol. 1990 Apr-Jun;3(2):116. doi: 10.1177/089198879000300212. PMID: 2206259.

  • * Roizen MF. Monoamine oxidase inhibitors: are we condemned to relive history, or is history no longer relevant? J Clin Anesth. 1990 Sep-Oct;2(5):293-5. doi: 10.1016/0952-8180(90)90072-b. PMID: 2271191.

  • * Ghoneim MM. Drug interaction in anaesthesia. A review. Can Anaesth Soc J. 1971 Jul;18(4):353-75. doi: 10.1007/BF03025688. PMID: 4109886.

  • * Bouletreau P, Ducluzeau R. [Fatal therapeutic complications]. Sem Hop. 1969 Jun 26;45(30):2093-9. PMID: 4308665.

  • * Vourc'h G. [Pharmacologic action of sympathomimetics]. Anesth Analg (Paris). 1969 Sep-Oct;26(5):685-91. PMID: 4391672.

  • * De Séréville JE, Boer C, Rambert FA, Duteil J. Lack of pre-synaptic dopaminergic involvement in modafinil activity in anaesthetized mice: in vivo voltammetry studies. Neuropharmacology. 1994 Jun;33(6):755-61. doi: 10.1016/0028-3908(94)90115-5. PMID: 7936113.

  • * Brandão F, Paiva MQ, Albino-Teixeira A, Serrão P, Guimarães S. Homogeneous or heterogeneous distribution of systemically administered adrenaline: organ dependence. Naunyn Schmiedebergs Arch Pharmacol. 1996 Apr;353(5):579-83. doi: 10.1007/BF00169179. PMID: 8740153.

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.